Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue...
Drug safety advice
- Piperacillin/tazobactam: compatibility of generics differs from brand leader (Tazocin)
- Temsirolimus: severe hypersensitivity reactions during infusion
- Tacrolimus (Advagraf and Prograf): risk of serious medication errors
Yellow Card scheme update
- You can report side-effects from unlicensed medicines on a Yellow Card
Hot topic
- Second birthday for European regulation of children’s medicines
Other information from the MHRA
- Patient Information Leaflet of the month: Tanatril
- Consultation: reclassification of Flomax to pharmacy (P) availability without prescription
Drug Safety Update: Volume 2 Issue 6, January 2009 
